stockrow
Friday 6 November 2026
Export RBOT’s income statement to Excel — free account
Vicarious Surgical Inc.
RBOT Healthcare Medical Devices
- EPS
- +60.4%
- Free cash flow
- +47.3%
Quarter to March 2026, against a year earlier
0.00
0.00
NaN
Follow RBOT
Alert me
Vicarious Surgical Inc. (RBOT) P/E ratio
Vicarious Surgical Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 112× (May 2022) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|
Against its own ten years
Low 0.0×
High 112×
Ten-year median
0.0×
Current reading's percentile
84
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PAVM PAVmed Inc. compare | n/m |
| PETV PetVivo Holdings, Inc. compare | n/m |
| CTSO Cytosorbents Corporation compare | n/m |
| ALUR Allurion Technologies, Inc. compare | n/m |
| HSCS HeartSciences Inc. compare | n/m |
| RBOT Vicarious Surgical Inc. | n/m |
| LFWD Lifeward Ltd. compare | n/m |
| ARAY Accuray Incorporated compare | n/m |
| ITOC iTonic Holdings Ltd. compare | — |
| Medical Devices industry median | 24.9× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)